ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)

Institutions:

• Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
• Department II of Thoracic Medicine, Hunan Cancer Hospital, Changsha, China
• Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China
• Department of Respiratory Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
• The Third Department of Chemotherapy, Weihai Municipal Hospital, Weihai, China
• Department of Oncology, Linyi Cancer Hospital, Linyi, China
• Medical Oncology, Chinese People's Liberation Army General Hospital, Beijing, China
• Department I of Thoracic Oncology, Peking University Cancer Hospital & Institute, Beijing, China
• Department of Oncology, Beijing Chao-Yang Hospital, Beijing, China
• Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China
• Department of Medical Oncology, Xuzhou Central Hospital, Xuzhou Medical University, Xuzhou, China
• Department of Oncology, Shanghai Pulmonary Hospital, Shanghai, China
• Medical Oncology, Tianjin Cancer Hospital, Tianjin Medical University, Tianjin, China
• Cancer Hospital, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Teaching Hospital of Fujian Medical University, Department of Medical Oncology, Xiamen, China
• Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
• Oncology Department, Affiliated Hospital of Jining Medical University, Jining, China
• Department of Respiratory Medicine, Peking Union Medical College Hospital, Beijing, China
• Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
• Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China